|
|
Quest Diagnostics Inc (DGX) |
|
|
|
| |
DGX's Income from Cont. Operations Growth by Quarter and Year
Quest Diagnostics Inc's Income from Cont. Operations results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Income from Cont. Operations Growth Y/Y▼
|
Income from Cont. Operations Growth Y/Y▼
|
| DGX Income from Cont. Operations (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
413.00
|
609.00
|
265.00
|
| III Quarter |
September |
-
|
527.00
|
591.00
|
226.00
|
| II Quarter |
June |
-
|
650.00
|
193.00
|
219.00
|
| I Quarter |
March |
373.00
|
490.00
|
106.00
|
176.00
|
| FY |
|
373.00
|
2,080.00
|
1,499.00
|
886.00
|
| DGX Income from Cont. Operations first quarter 2022 Y/Y Growth Comment |
Quest Diagnostics Inc reported decline in Income from Cont. Operations in the first quarter 2022 by -23.88% to $ 373.00 millions, from the same quarter in 2021.
The contraction in the first quarter 2022 Quest Diagnostics Inc's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations growth of 3.03%.
Among companies who have reported first quarter 2022 results in the Medical Laboratories industry only one Company has achieved higher year on year Income from Cont. Operations results in the first quarter 2022. While Quest Diagnostics Inc' s Income from Cont. Operations fall of -23.88% ranks overall at the positon no. 91 in the first quarter 2022.
|
| DGX Income from Cont. Operations ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-32.18 % |
129.81 % |
34.52 % |
| III Quarter |
September |
- |
-10.83 % |
161.5 % |
-0.44 % |
| II Quarter |
June |
- |
236.79 % |
-11.87 % |
-6.01 % |
| I Quarter |
March |
-23.88 % |
362.26 % |
-39.77 % |
-6.88 % |
| FY |
|
- |
38.76 % |
69.19 % |
4.73 % |
DGX Income from Cont. Operations (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-21.63 % |
3.05 % |
17.26 % |
| III Quarter |
September |
- |
-18.92 % |
206.22 % |
3.2 % |
| II Quarter |
June |
- |
32.65 % |
82.08 % |
24.43 % |
| I Quarter |
March |
-9.69 % |
-19.54 % |
-60 % |
-10.66 % |
| FY (Year on Year) |
|
- |
38.76 % |
69.19 % |
4.73 % |
| Income from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 46.2 % |
3.03 % |
-33.42 % |
| (Sep 30 2020) |
|
(Sep. 30, 2014) |
|
|
| Income from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 46.2 % |
3.03 % |
-33.42 % |
| (Sep 30 2020) |
|
(Sep. 30, 2014) |
|
| Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Quest Diagnostics Inc's Q/Q Income from Cont. Operations Growth
| Income from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 206.22 % |
8.8 % |
-64.1 % |
| (Sep 30 2020) |
|
|
| DGX's I. Quarter Q/Q Income from Cont. Operations Comment |
In the I. Quarter 2022 Quest Diagnostics Inc disclosed drop in Income from Cont. Operations from the forth quarter by -9.69% to $ 373.00 millions, from $ 413.00 millions achived in the previous reporting period.
It's not important problem, as Quest Diagnostics Inc's Income from Cont. Operations frequently seem to plunge in the I. Quarter Molly O. Scott, Medical Laboratories industry veteran located in Boston told.
Within Medical Laboratories industry Quest Diagnostics Inc achieved highest sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 59. |
|
|
|
| Income from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 206.22 % |
8.8 % |
-64.1 % |
| (Sep 30 2020) |
|
|
| DGX's I. Quarter Q/Q Income from Cont. Operations Comment |
In the I. Quarter 2022 Quest Diagnostics Inc reported drop in Income from Cont. Operations sequentially by -9.69% to $ 373.00 millions, from $ 413.00 millions released in the previous quarter.
As we look into current slump in the I. Quarter 2022, we suppose to presume, that usually I. Quarter performance occur weaker in contrast to the preciding period, Molly O. Scott, Medical Laboratories industry veteran located in Boston said.
Within Medical Laboratories industry Quest Diagnostics Inc achieved highest sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 59. |
|
Quest Diagnostics Inc's 12 Months Income from Cont. Operations Growth Year on Year
Income from Cont. Operations TTM Growth |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
| Cumulative Income from Cont. Operations 12 Months Ending |
$ 1,963.00 |
$ 2,080.00 |
$ 2,276.00 |
$ 2,340.00 |
$ 1,883.00 |
| Y / Y Income from Cont. Operations Growth (TTM) |
4.25 % |
38.76 % |
97.06 % |
196.2 % |
130.76 % |
| Year on Year Income from Cont. Operations Growth Overall
Ranking |
# 71 |
# 975 |
# 482 |
# 20 |
# 22 |
| Seqeuential Income from Cont. Operations Change (TTM) |
-5.63 % |
-8.61 % |
-2.74 % |
24.27 % |
25.62 % |
| Seq. Income from Cont. Operations Growth (TTM) Overall
Ranking |
# 91 |
# 1834 |
# 1660 |
# 44 |
# 705 |
| Cumulative Income from Cont. Operations growth
Comment |
With the quarterly Income from Cont. Operations reported in the Mar 31 2022 period, Quest Diagnostics Inc's cumulative twelve months Income from Cont. Operations were $ 1,963 millions, company would post below average annual Income from Cont. Operations growth of 25.62% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Quest Diagnostics Inc's Income from Cont. Operations growth from the 413% growth in Dec 31 2021. Comparing the results with it's peers in Medical Laboratories industry, Quest Diagnostics Inc's trailing twelve months Income from Cont. Operations growth, were the second highest.
Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 71, from total ranking in previous quarter at 975. |
| Income from Cont. Operations TTM Q/Q Growth Statistics |
| High |
Average |
Low |
46.2 % |
3.03 % |
-33.42 % |
|
|
|
|
|
| Income from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
196.2 % |
13.37 % |
-35.86 % |
|
|
|
| Income from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 2 |
| Sector |
# 4 |
| S&P 500 |
# 91 |
|
| Cumulative Income from Cont. Operations growth
Comment |
With the quarterly Income from Cont. Operations reported in the Mar 31 2022 period, Quest Diagnostics Inc's cumulative twelve months Income from Cont. Operations were $ 1,963 millions, company would post below average annual Income from Cont. Operations growth of -35.86% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Quest Diagnostics Inc's Income from Cont. Operations growth from the 413% growth in Dec 31 2021. Comparing the results with it's peers in Medical Laboratories industry, Quest Diagnostics Inc's trailing twelve months Income from Cont. Operations growth, were the second highest.
Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 71, from total ranking in previous quarter at 975. |
| Income from Cont. Operations TTM Q/Q Growth Statistics |
| High |
Average |
Low |
46.2 % |
3.03 % |
-33.42 % |
|
|
|
| Income from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
196.2 % |
13.37 % |
-35.86 % |
|
|
|
| Income from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 2 |
| Sector |
# 4 |
| S&P 500 |
# 91 |
|
